on Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)
Eckert & Ziegler Hosts 4th Boston Radionuclide Theranostics Forum
On May 29, 2026, Eckert & Ziegler SE completed the 4th Boston Radionuclide Theranostics Forum. This event gathered key figures from the radiopharmaceutical sector to discuss accelerating developments in radionuclide theranostics. The forum, held as a precursor to ASCO and SNMMI conferences, emphasized urgency in turning scientific advances into clinical impacts amidst global competition and complex regulations.
The half-day event was fully booked, offering expert presentations and panel discussions. Attendees explored the radiopharmaceutical ecosystem, strategies for industry acceleration, isotope supply, and approval processes. Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE, stressed the importance of collaboration in advancing radiopharmaceuticals.
The invitation-only forum provided a space for candid dialogue and strategic partnerships, hosted by Morrison Foerster and sponsored by Solomon Partners. The 5th forum is scheduled for June 3, 2027.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news